Abstract:\nThis focused review is designed to analyze the myocardial injury associated with COVID-19. We aim to gather relevant information conducted in different parts of the world that describes the forementioned relationship.\n\nMethodology: For this study, a total 10 of studies were included. We searched electronic articles, from November 2019 to January 2021, on PubMed, Cochrane, Web of Science, online Willey library, and Science Direct websites by using keywords related to myocardial infraction and Corona virus.\n\nResults: We observed the severity of myocardial injury in COVID patients and found elevated levels of troponin as a result of myocardial inflammation. Also, we selected studies that compared the myocardial injury events before COVID and during the COVID period. During analysis, we observed that 7-40% of researchers used the same definition of myocardial injury which they analyze with echocardiographic and electrocardiographic imaging. Myocardial injury is also responsible for high complications which may eventually result in an increased mortality rate of patients during hospital admission. Studies reflects a great association between the great amount of cardiac troponin and infectious biomarkers especially with D dimer, and other inflammatory responses including the amount of ferritin, IL-6, C-reactive protein of Covid patients. Among many patients, severe hypoxemia was observed which need mechanical ventilation.\nConclusion: We conclude that the SARS- CoV-2 infection has huge impact on cardiovascular system. We conclude that serum troponin elevations and ventricular dysfunctions are the major reasons for myocardial infarction. Other factors like comorbidities also play a vital role in MI injury. Asymptomatic MI leads to a high mortality rate which needs to be monitored at the initial stage of the disease.